Abstract

BackgroundStroke mimics account for up to one-third of acute stroke admissions and are a heterogeneous entity which pose diagnostic challenges. Diagnosing such patients is however crucial to avoid delays in treatment and potentially harmful medication prescription. We aimed at describing the magnitude, clinical characteristics and short-term outcomes of stroke mimics in patients clinically diagnosed with a stroke.MethodsThis prospective study enrolled patients admitted with a World Health Organization clinical criteria for stroke at a tertiary hospital in Tanzania. Baseline data was collected and the simplified version of the FABS scale was used to determine its usefulness in predicting stroke mimics. The National Institute of Health Stroke Scale and Modified Rankin Scale were used to assess for admission stroke severity and outcomes respectively.ResultsAmong 363 patients with suspected stroke on admission, the final diagnosis was stroke mimics in 24 (6.6%) who had a mean age of 65.8 ± 15 years. Patients with stroke mimics were less likely to have cardiovascular risk factors for stroke including premorbid hypertension (7 (29.2%) vs 263 (77.6%), p < 0.001) and increased waist-hip ratio (9 (37.5%) vs 270 (79.6%) p < 0.001) for mimics and true strokes respectively. Clinical findings such as hypertension and the presence of cortical features in neurological examination occurred less in patients with stroke mimics. The simplified FABS score of ≥3 could identify patients with stroke mimics with a sensitivity and specificity of 38 and 80% respectively. The most common causes of mimics were brain tumors 6 (25%), meningoencephalitis 4 (16.7%) and epileptic seizures 3 (12.5%). The majority of patients with stroke mimics had severe disease on admission and the 30-day mortality in these patients was 54.5%.ConclusionsIn the present study, the proportion of stroke mimics among patients clinically diagnosed with stroke was 6.6% and brain tumors was a common etiology. Stroke mimics were less likely to have cardiovascular risk factors and cortical signs during evaluation. We recommend further studies that can help develop clinical scales used for predicting stroke mimics in an African population.

Highlights

  • Stroke mimics account for up to one-third of acute stroke admissions and are a heterogeneous entity which pose diagnostic challenges

  • In modern era where thrombolytics are widely used in treating acute stroke, evidence indicates that as many as a 15% of patients treated with tissue plasminogen activator (t-PA) are stroke mimics (SM) for which the therapy is not indicated [3]

  • Brain imaging was used to confirm the diagnosis of stroke and these were termed as true strokes with either a non-contrast brain computed tomography (CT) scan or Magnetic Resonance Image (MRI) interpreted by a senior Radiologist

Read more

Summary

Introduction

Stroke mimics account for up to one-third of acute stroke admissions and are a heterogeneous entity which pose diagnostic challenges Diagnosing such patients is crucial to avoid delays in treatment and potentially harmful medication prescription. Stroke is a clinical diagnosis as endorsed by World Health Organization (WHO), defined as rapidly developing clinical signs of focal or global disturbance in cerebral function lasting more than 24 h or leading to death with no apparent cause other than that of vascular origin [1]. It is a medical emergency and an early diagnosis is of paramount importance. This results in unnecessary diagnostic tests, invasive procedures and longer hospital stay leading to an increased cost to the patient

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call